The chemical substance known as (6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione, with the CAS number 103744-18-9, is a synthetic steroid that exhibits glucocorticoid activity. It is characterized by its structural features, including a pregnane backbone with hydroxyl groups at the 11 and 21 positions, and a methyl group at the 6 position. This compound is known for its anti-inflammatory and immunosuppressive properties, making it relevant in therapeutic applications, particularly in the treatment of various inflammatory and autoimmune conditions. The presence of double bonds in the steroid structure contributes to its biological activity and receptor binding affinity. Additionally, the specific stereochemistry at the 6α and 11β positions influences its pharmacokinetic properties and potency. As a synthetic derivative, it may also exhibit differences in metabolism and side effects compared to naturally occurring corticosteroids. Overall, this compound represents a significant class of medications used in clinical settings for managing inflammatory responses.

(6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione

103744-18-9: The chemical substance known as (6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione, with the CAS number 103744-18-9, is a synthetic steroid that exhibits glucocorticoid activity. It is characterized by its structural features, including a pregnane backbone with hydroxyl groups at the 11 and 21 positions, and a methyl group at the 6 position. This compound is known for its anti-inflammatory and immunosuppressive properties, making it relevant in therapeutic applications, particularly in the treatment of various inflammatory and autoimmune conditions. The presence of double bonds in the steroid structure contributes to its biological activity and receptor binding affinity. Additionally, the specific stereochemistry at the 6α and 11β positions influences its pharmacokinetic properties and potency. As a synthetic derivative, it may also exhibit differences in metabolism and side effects compared to naturally occurring corticosteroids. Overall, this compound represents a significant class of medications used in clinical settings for managing inflammatory responses.

CAS 103744-18-9

(6α,11β)-11,21-Dihydroxy-6-methyl-pregna-1,4-diene-3,20-dione

Methylprednisolone Impurity 55

Ref: 4Z-P-111260